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The aza-Morita–Baylis–Hillman (azaMBH) reaction has been studied for electronically and sterically
deactivated Michael acceptors. It is found that electronically deactivated systems can be converted with
electron-rich phosphanes and pyridines as catalysts equally well. For sterically deactivated systems clearly
better catalytic turnover can be achieved with pyridine catalysts. This is in accordance with the calculated
affinities of the catalysts towards different Michael-acceptors.
Introduction
The aza-Morita–Baylis–Hillman (azaMBH) reaction is a syn-
thetically useful C–C bond forming reaction involving the coup-
ling of imines with Michael acceptors to form highly
functionalized amines (Scheme 1).1–3,8 Despite the impressive
development of various protocols for the enantioselective
azaMBH reaction involving either chiral Lewis bases or combi-
nations of achiral Lewis bases with chiral protic co-catalysts,4–7
the effective transformation of sterically and/or electronically
deactivated Michael acceptors still provides an ambitious
challenge.
The azaMBH reaction is currently considered to involve
initial attack of the Lewis base catalyst on the Michael ac-
ceptor,3c,d,4,9,10 followed by addition of the resulting zwitterionic
enolate I to the imine substrate. Subsequent intramolecular
proton transfer within zwitterionic intermediate II and elimin-
ation of the nucleophilic catalyst close the catalytic cycle. Pre-
vious kinetic studies by Lloyd-Jones et al.11 indicate that
reaction rates are most likely limited by the imine addition and/
or the subsequent proton transfer step. The step most strongly
affected by deactivated Michael acceptors is the initial nucleo-
philic addition step, and sluggish reaction rates for this class of
substrates may simply derive from the reduced preequilibrium
formation of zwitterionic enolate I. This implies that the use of
Lewis base catalysts with increased carbon basicity will predicta-
bly lead to higher turnover rates. In the following we show that
this is indeed the case.
Results and discussion
Initial experiments were performed for the reaction of p-chloro-
tosylimine 1a with methyl vinyl ketone (2a) using the nucleophi-
lic catalysts depicted in Fig. 2 in CDCl3 as the solvent
(Scheme 2, Table 1). Methyl vinyl ketone (2a) has been selected
here as a reference Michael acceptor of known high reactivity.
The reaction was conveniently monitored by 1H NMR spec-
troscopy following the signals of imine 1a and amine product
3aa. Turnover curves were fitted using a simple kinetic scheme
involving pre-equilibrium formation of zwitterionic enolate I and
the follow-up addition/rearrangement step with imine. This
kinetic model involving only three rate constants as variable par-
ameters is closely similar to that used in previous studies,11 but
does not include any type of co-catalysis by product molecules
or other protic additives. More complex models involving a
larger number of steps have also been explored, but not found to
perform substantially better (see ESI† for further details). An
example for the turnover curve with catalyst 4d is depicted in
Fig. 1.
Scheme 1 The mechanism of the aza-Morita–Baylis–Hillman
(azaMBH) reaction of imines with Michael acceptors.
†This article is part of the joint ChemComm–Organic & Biomolecular
Chemistry ‘Organocatalysis’ web themed issue.
‡Electronic supplementary information (ESI) available: Details of the
kinetic measurements, synthesis and theoretical calculations. See DOI:
10.1039/c2ob07058h
Department of Chemistry, LMU Muenchen, Butenandtstr. 5-13, 81377
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The reaction half-life time t1/2 listed in Table 1 as the most rel-
evant kinetic parameter corresponds to the time required for 50%
conversion of the initially used imine substrate and is obtained
from the simulated turnover curve. Methyl cation affinity (MCA)
values are available for most of the catalysts shown in Fig. 2 and
reflect the Lewis basicity of these species towards the methyl
cation as the smallest carbon electrophile (Table 1).14
In the group of nitrogen-based catalysts the reaction is rather
sluggish in the presence of catalysts of low Lewis basicity such
as DABCO (4a), yielding only 8% turnover after 10 h reaction
time. Extrapolating this rate in a linear fashion to 50% turnover
yields an approximate half-life time of 3750 minutes. Signifi-
cantly higher rates are observed for pyridine catalysts such as
DMAP (4b) and PPY (4d). Best results are obtained with the
recently developed 3,4-diaminopyridine catalysts such as 4f,
with the tricyclic aminopyridine 4k,13 or with some of the phos-
phanes based on the PPh3 motif. In all these latter cases com-
plete turnover is achieved after 4 h. For catalyst 4f it has been
Fig. 2 Catalysts used in the azaMBH reactions.
Scheme 2 The azaMBH reaction of N-tosylimine 1a with MVK (2a)
in CDCl3.
Table 1 Results for the azaMBH reaction with MVK (2a) shown in
Scheme 2
Entry Catalyst Time [h]
Conversionac
[%]
t1/2
c
[min]
MCA
[kJ mol−1]
Using 10 mol% catalyst
1 DABCO
(4a)
10 8 3750f +562.2
2 DMAP
(4b)
10 56 475 +581.2
3 4c 10 83 193 +589.1
4 PPY (4d) 10 86 146 +590.1
5 4ng 8 93 72 +636.8
6 4e 5 98 41 +609.0
7 4mg 4 96 26 +621.6
8 4lg 4 99 25 +618.7
9 4f 3 99(98)b 23 +616.0
10 4k 3 98 20 +602.7
11 5i – – nce +494.1
12 5h – – nce +643.9
13 5d 34 95 271d +586.5
14 PPh3 (5a) 4 99 35 +618.4
15 5b 3 98 32 +651.0
16 5f 3 99 27 +637.2
17 5e 2 98 26 +630.2
18 5c 3 99 25 +646.7
19 5g 2 99 22 +643.9
Using 5 mol% catalyst
20 4e 10 97 75 +609.0
21 4j 10 99 55 –
22 4h 10 99 53 –
23 4i 10 99 53 –
24 4f 10 99(92)b 53 +616.0
25 4g 10 99 49 –
26 4k 5 99 40 +602.7
27 PPh3 (5a) 8 98 69 +618.4
28 5c 7 98 64 +646.7
29 5b 9 95 60 +651.0
30 5f 5 99 46 +637.2
31 5e 4 99 45 +630.2
32 5g 4 99 41 +643.9
Using 2.5 mol% catalyst
33 PPh3 (5a) 13 95 146 +618.4
34 5g 10 92 80 +643.9
35 4k 10 96 77 +602.7
36 5f 10 95 76 +637.2
aDetermined by 1H NMR. b Isolated yield. c 0.125 M imine, 1.2 eq.
MVK. d 20% catalyst. eNo conversion. f Extrapolated value. gRef. 12
Fig. 1 Results for the reaction of MVK (2a) with imine 1a catalyzed
by 10 mol% 4d in CDCl3.
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 3210–3218 | 3211
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verified that this translates into an isolated yield of 98% after
product isolation and purification. With respect to t1/2 values the
tricyclic pyridine 4k is found to be the fastest catalyst, closely
followed by pyridine 4f. This closely parallels recent results for
the Lewis base-catalyzed acylation of tertiary alcohols.16 Phos-
phane 5g is the most active phosphane catalyst studied here, but
is only moderately faster than other triarylphosphanes carrying
electron-donating substituents in para position such as 5c.
Replacing one of the phenyl groups in PPh3 (5a) by a cycloalkyl
substituent as in 5e also enhances the catalytic activity, but also
leads to a notable increase in phosphane oxidation (and thus
deactivation). Rather poor results are obtained for phosphanes
with electron-withdrawing substituents (such as 5i) or with steri-
cally demanding substituents in ortho position (as in 5h).
With rate data for a larger number of systems in hand we can
test for a possible quantitative correlation between catalyst basi-
city as quantified by MCA values and reaction rate. As can be
seen in Fig. 3 a linear correlation between basicity and reaction
rate exists for catalysts of low Lewis basicity (that is, with MCA
values less than 610 kJ mol−1). For more Lewis basic com-
pounds a saturation of the reaction rate at high level is found.
The only catalyst not following this general trend is sterically
hindered phosphane 5h, whose rather large MCA value of
643.9 kJ mol−1 equals that of the most active phosphane 5g, but
whose very low reactivity did not allow for determining the reac-
tion rate quantitatively. The intrinsically good Lewis basicity of
catalyst 5h is thus completely compensated by steric effects in
reactions involving the substrate pair 1a/2a.
The absolute reaction rates obtained for electron-rich pyridines
and phosphanes are somewhat too large at catalyst loadings of
10 mol% to obtain a precise picture of catalytic performance. To
this end several of the reactions have been reinvestigated with a
lower catalyst loading of 5 mol% (Table 1), now also including
derivatives of catalyst 4f with alkyl sidechains of variable
lengths. The largely similar t1/2 values determined for 3,4-
diaminopyridines 4f–4j imply, however, that the increasingly
longer alkyl side chains in these compounds do not lead to an
enhancement of the electron density of the pyridine ring (and
thus not to an increase in catalytic performance). Tricyclic
pyridine 4k thus remains the most effective catalyst found here,
closely followed by phosphane 5g.
For selected catalysts the reaction was also investigated at a
loading of 2.5 mol%. Together with the results obtained at
higher loadings this allows for an approximate analysis of the
dependence of the reaction rate on the catalyst loading (Fig. 4).
Measurements at even lower loadings were accompanied by oxi-
dation of the phosphane catalysts in a significant manner and
were thus not pursued any further (see ESI† for details). The
results for the most stable catalysts, e.g. 4k and 5a indicate that
reaction rates vary linearly with the catalyst concentration (cf.
Fig. 4). In mechanistic terms this implies the involvement of a
single catalyst molecule in the rate limiting step. For both of
these catalysts the interpolation curve is observed to pass
through the intercept, reflecting minimal background reactivity.
This latter point is also in line with rate measurements performed
in the absence of catalysts.
Tosylimine 1a was also used in benchmark reactions with
ethyl acrylate (2b) as the Michael acceptor. Due to the much
lower reactivity of this latter compound, reasonable turnover
times require higher substrate concentrations and a catalyst
loading of 25 mol% (Scheme 3, Table 2).
With these reaction conditions full conversion can be obtained
after a maximum of five days. The phosphane catalyst 5f turned
out to be the most effective choice in this series with complete
turnover after two days, although pyridine 4k is almost equally
active. The half-life time of triphenylphosphane 5a is more than
two times longer than the two best catalysts.
In order to explore the effects of steric hindrance on the cata-
lytic efficiency of pyridine and phosphane catalysts, the
azaMBH reaction of cyclohexenone (2c) was studied under the
same conditions used for acrylate 2b (Scheme 4, Table 3).
Fig. 4 Correlation of the rates of reaction of MVK (2a) with 1a vs. the
concentration of the catalysts 4k and 5a.
Scheme 3 The azaMBH reaction of N-tosylimine 1a with ethyl acry-
late (2b) in CDCl3.
Fig. 3 Correlation of reaction rates vs. MCA values for the reaction of
MVK (2a) and 1a with 10 mol% catalyst.
3212 | Org. Biomol. Chem., 2012, 10, 3210–3218 This journal is © The Royal Society of Chemistry 2012
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The reaction of cyclic ketone 2c with DABCO (4a) as catalyst
shows almost no conversion. For the pyridine catalysts, in con-
trast, good turnover can be observed in particular for the 3,4-
diaminopyridine catalyst 4f and the tricyclic pyridine 4k. With
these catalysts, essentially complete turnover is achieved after
30 h reaction time, which translates into an isolated yield of
adduct 3ac of 98% for 4f. In surprising contrast to the result
obtained for the acyclic Michael acceptors 2a and 2b, there is
practically no turnover when using any of the phosphane cata-
lysts for reaction with cyclohexenone 2c. This unexpected result
may indicate a generally larger sensitivity of triarylphosphanes
to steric demands of the Michael acceptor, or may alternatively
indicate the presence of stabilizing contacts between phosphane
catalyst and carbonyl oxygen atom in the zwitterionic enolates I
formed in the initial addition steps (see Scheme 1). As indicated
in Scheme 1 this latter type of interaction is only possible in
acyclic Michael acceptors for geometric reasons. In order to
differentiate between these two effects, additional measurements
have been performed for acyclic Michael acceptor trans-3-
penten-2-one (2d), in which the center of attack also carries an
alkyl substituent.
Although the reaction of the sterically hindered ketone 2d is
the slowest of the four investigated azaMBH reactions, full con-
version can be obtained for pyridine catalysts 4f and 4k after 29
days. Product isolation and characterization indicates formation
of a single stereoisomer 3ad with (E)-configuration according to
NOE experiments and X-ray analysis. In contrast to the two pyri-
dine catalysts 4f and 4k, there is no significant turnover for tri-
arylphosphanes 5a or 5f. Since the acyclic nature of alkene 2d
does allow for contacts between carbonyl oxygen and phosphane
catalysts in zwitterionic intermediate I, this latter result implies
that triaryl phosphane catalysts are intrinsically more sensitive to
the steric demands of Michael acceptors than pyridine catalysts.
The largely different reactivities of the four Michael acceptors
2a–2d are already apparent from the conversion data in Tables
1–4. It was nevertheless desirable to compare the catalytic prop-
erties of the best catalysts 4k and 5f in transformations with
these four substrates under strictly identical conditions. To this
end, an additional set of rate measurements was performed using
tosylimine 1a at 0.25 M concentration in combination with 4.0
eq. Michael acceptor and 25 mol% catalyst. As can be seen from
the turnover plot for catalysts 4k and 5a in Fig. 5, the reaction is
now so fast for MVK (2a) as the substrate that the reaction is
essentially complete within 3 minutes (4k) and 20 minutes (5a)
respectively.
For the azaMBH reaction with MVK (2a) and 4k as catalyst,
the reaction half-life time is roughly one minute. The half-life
times are dramatically increased for the electronically deactivated
Michael acceptor 2b (612 minutes), as well as for sterically hin-
dered Michael acceptors (2c, 242 minutes; 2d, 1890 minutes).
The difference in the reactions of MVK (2a) and acrylate 2b of
1 : 612 is significantly larger as compared to the ratio of 1 : 38
found in kinetic studies for the addition of DMAP (4b) to MVK
and methyl acrylate in aqueous solution.24 The half-life time in
the case of phosphane 5a as catalyst (cf. Fig. 5) is four minutes
(MVK (2a)) and 1384 minutes (ethyl acrylate (2b)) respectively.
As already mentioned above the phosphanes are not catalytically
active in the case of sterically hindered Michael-acceptors
(2c and 2d).
Table 2 Results for the azaMBH reaction with ethyl acrylate (2b)
using 25 mol% catalyst as shown in Scheme 3
Entry Catalyst Time [d] Conversionab [%] t1/2 [min]
1 5a 5 99 1384
2 4f 4 99 747
3 4k 3 99 612
4 5f 2 99 595
aDetermined by 1H NMR. b 0.25 M imine, 4.0 eq. 2b.
Scheme 4 The azaMBH reaction of N-tosylimine 1a with cyclohexe-
none (2c) in CDCl3.
Table 3 Results for the azaMBH reaction with cyclohexenone (2c)
using 25 mol% catalyst as shown in Scheme 4
Entry Catalyst Time [h] Conversionac [%] t1/2
c [min]
1 DABCO (4a) 40 4 —
2 Quinuclidine 40 25 —
3 DMAP (4b) 40 36 —
4 PPY (4d) 30 43 —
5 4f 30 99(98)b 264
6 4k 30 98 242
7 4l 40 95 456
8 4m 72 98 581
9 4n 72 97 758
10 PPh3 (5a) 40 <3 —
11 5f 40 <3 —
aDetermined by 1H NMR. b Isolated yield. c 0.25 M imine, 4 eq. 2c.
Table 4 Results for the azaMBH reaction with trans-3-penten-2-one
(2d) using 25 mol% catalyst as shown in Scheme 5
Entry Catalyst Time [d] Conversionac [%] t1/2
c [h]
1 4f 29 92 164
2 4k 29 98(93)b 120
3 PPh3 (5a) 5 <2 —
4 5f 5 <2 —
aDetermined by 1H NMR. b Isolated yield. c 0.125 M imine, 4 eq. 2d.
Scheme 5 The azaMBH reaction of N-tosylimine 1a with trans-3-
penten-2-one (2d) in CDCl3 solution.
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 3210–3218 | 3213
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Suspecting that the largely different reaction rates for Michael
acceptors 2a–2c are, at least in part, due to the energetics of the
first step of the catalytic cycle shown in Scheme 6, the reaction
free energies for this step in CHCl3 solution have been calculated
for catalysts 4f and 5a using a theoretical protocol optimized for
the description of zwitterionic species in organocatalytic reac-
tions (Fig. 6).21
The reaction free energies for the addition of catalysts 4f and
5a to alkenes 2a–2c are all large and positive, implying a rather
unfavorable position of the preequilibrium. In qualitative agree-
ment with the measured rate data, the most stable intermediate is
calculated for the addition of 4f to MVK (2a), closely followed
by the adduct formed from the same alkene with 5a. The zwitter-
ionic intermediates I formed through reaction with the electroni-
cally deactivated acrylate 2b are less favourable for both
catalysts, again with a small preference for catalyst 4f. This is
again in agreement with available rate data. For sterically
hindered alkene 2c the agreement between calculated stabilities
and measured rate data are less satisfactory in that the (compara-
tively fast) reaction with catalyst 4f is not compatible with the
very low calculated stability of the respective intermediate I. The
least stable intermediate studied here is the adduct formed
through reaction of alkene 2c with phosphane 5a, which is again
in satisfactory agreement with the non-observation of product
formation. The energetically best conformations of the MVK-
adducts with 4f and 5a are depicted in Fig. 7.
In both structures we can identify a close contact between the
enolate oxygen atom and one of the catalyst C–H bonds. In cata-
lyst 4f this interaction involves the α-C–H bond of the pyridine
ring. This is closely similar to interactions identified between
acylpyridinium ions and carboxylate counter ions in pyridine-
catalyzed acylation reactions.22,23 In the adduct formed with
PPh3 (5a) the enolate oxygen atom is in direct contact with one
of the phenyl ortho-C–H bonds.
In order to explore the synthetic scope of the protocols devel-
oped above, the reactions with MVK (2a) as the Michael accep-
tor were repeated with 3,4-diaminopyridine catalyst 4f at 5 mol%
loading for a number of different tosylimines (Scheme 7,
Table 5). The entries in Table 5 are ordered by σpara
parameters.20,25
It is gratifyingly found that catalyst 4f used at 5 mol% loading
yields acceptable turnover times and good synthetic yields even
for deactivated tosylimines carrying donor substituents such as
1h. Reaction times are, of course, much shorter for acceptor sub-
stituted imines such as 1b and 1c. The latter are the fastest
imines which can also be found by their σpara parameters. We
note in passing that the variations in reaction times and yields
observed here are fully compatible with, at least partially, rate-
limiting addition of zwitterionic intermediates I to the imine sub-
strates. A completely analogous set of experiments was per-
formed with catalyst 4f for the sterically hindered Michael
acceptor cyclohexenone 2c (Scheme 8, Table 6).
Reactions with sterically hindered Michael acceptor 2c are,
even at the much higher catalyst and substrate concentrations
used now, significantly slower as compared to those involving
Fig. 5 Turnover curves for 4k (top) and 5a (bottom) for the azaMBH
reactions of tosylimine 1a (0.25 M) with 4 eq. of Michael acceptors 2a
(filled squares), 2b (filled triangles), 2c (empty circles) or 2d (empty
diamonds).
Scheme 6 Formation of adducts between catalyst and Michael-
acceptors.
Fig. 6 Reaction free energies ΔG298,CHCl3 for the formation of zwitter-
ionic enolates I involving catalysts 4f and PPh3 (5a) and different
Michael acceptors (2a–2c).
3214 | Org. Biomol. Chem., 2012, 10, 3210–3218 This journal is © The Royal Society of Chemistry 2012
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MVK (2a). After sufficiently long reaction times the correspond-
ing azaMBH products 3 can, however, be isolated in good to
excellent yields in all cases.
Conclusion
An effective protocol for the azaMBH reaction could be devel-
oped for all four Michael acceptors studied here. MVK (2a) is
the most reactive of the studied substrates. Having no back-
ground reaction MVK (2a) and the tosylimine (1a) can be con-
verted to the azaMBH product quantitatively in minutes. Most
pyridine and phosphane catalysts tested in this reaction lead to
full conversion in a short time. Using deactivated substrates, the
necessary reaction times for full conversion are significantly
increased. For the electronically deactivated Michael acceptor
(2b) pyridines as well as phosphanes can be used. In the case of
sterically hindered substrates (2c and 2d) only pyridines are cata-
lytically active, which illustrates the synthetic value of this class
of catalysts. All results found here are compatible with a reaction
mechanism involving preequilibrium formation of zwitterionic
intermediates from Michael acceptors and catalysts, and sub-
sequent rate-limiting addition to the imine (followed by intra-
molecular proton transfer and elimination of catalyst). The high
sensitivity of the azaMBH reaction rates to the steric and the
electronic properties of the Michael acceptor substrate found
here for the reaction in chloroform solution are, however, also
compatible with a partially rate-limiting first addition step.
Experimental
All air and water sensitive manipulations were carried out under
a nitrogen atmosphere using standard Schlenk techniques. Cali-
brated flasks for kinetic measurements were dried in the oven at
120 °C for at least 12 h prior to use and then assembled quickly
while still hot, cooled under a nitrogen stream and sealed with a
rubber septum. All commercial chemicals were of reagent grade
and were used as received unless otherwise noted. CDCl3 was
refluxed for at least one hour over CaH2 and subsequently dis-
tilled. 1H and 13C NMR spectra were recorded on Varian 300 or
Varian INOVA 400 machines at room temperature. All 1H chemi-
cal shifts are reported in ppm (δ) relative to TMS (0.00); 13C
chemical shifts are reported in ppm (δ) relative to CDCl3
(77.16). 1H NMR kinetic data were measured on a Varian
Mercury 200 MHz spectrometer at 23 °C. HRMS spectra
(ESI-MS) were carried out using a Thermo Finnigan LTQ FTFig. 7 Structures of the best conformations of zwitterionic enolates I
formed in the reaction of catalysts 4f and 5a with MVK (2a).
Scheme 7 The azaMBH reaction of MVK (2a) with various tosyli-
mines and catalyst 4f in CDCl3 solution.
Table 5 Results for the azaMBH reaction with MVK (2a) using 5 mol% catalyst 4f and selected tosylimines as shown in Scheme 7
Entry Ar Tosylimine Time [h] Yieldac [%] Conv.bc [%] Prod.
1 p-NO2-C6H4 1c 1.5 90 99 3ca
2 p-NC-C6H4 1b 1.5 94 99 3ba
3 p-Br-C6H4 1e 14 86 93 3ea
4 p-Cl-C6H4 1a 10 92 99 3aa
5 C6H5 1f 15 73 99 3fa
6 p-Me-C6H4 1g 20 80 89 3ga
7 p-MeO-C6H4 1h 48 74 85 3ha
a Isolated yield. bDetermined by 1H NMR. c 0.125 M imine, 1.2 eq. MVK.
Scheme 8 The azaMBH reaction of cyclohexenone (2c) with various
tosylimines and catalyst 4f in CDCl3 solution.
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 3210–3218 | 3215
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instrument. IR spectra were measured on a Perkin-Elmer FT-IR
BX spectrometer mounting ATR technology. All kinetic
measurements with reaction times longer than 24 h were
mechanically shaken; for each reaction the rotation speed was set
at 480 turns per minute. Analytical TLC was carried out using
aluminium sheets silica gel Si 60 F254.
General procedure (I) for benchmark reactions of MVK 2a with
10%/5% catalyst
0.5 mL from 5.0 mL of stock solution I (1a (220 mg,
0.75 mmol), MVK 2a (63 mg, 0.90 mmol) and trimethoxyben-
zene (27 mg)) and 0.1 mL from 2 mL of stock solution II
(0.15 mmol/0.075 mmol of catalyst) were mixed in a NMR-tube
and sealed.
General procedure (II) for benchmark reactions of 2b and 2c
with 25% catalyst
0.5 mL from 5.0 mL of stock solution I (1a (441 mg,
1.50 mmol), 2b/2c (6.0 mmol) and trimethoxybenzene
(67.2 mg)) and 0.1 mL from 2 mL of stock solution II
(0.375 mmol of catalyst) were mixed in a NMR-tube and flame-
sealed.
General procedure (III) for benchmark reactions of 2d with
25% catalyst
0.5 mL from 5.0 mL of stock solution I (1a (220 mg,
0.75 mmol), 2d (252 mg, 3.0 mmol) and trimethoxybenzene
(67.2 mg)) and 0.1 mL from 2 mL of stock solution II
(0.1875 mmol of catalyst) were mixed in a NMR-tube and
flame-sealed. The reaction mixture was directly subjected to
silica gel column chromatography and eluted with ethyl acetate
to give the corresponding azaMBH product.
3d: 1H NMR (300 MHz, CDCl3): δ = 1.91 (3H, d, J = 9.4 Hz,
CH3), 2.02 (3H, s, CH3), 2.39 (3H, s, CH3), 5.47 (1H, d, J =
10.3 Hz), 6.39 (1H, d, J = 10.4 Hz, NH), 6.74 (1H, q, J = 7.1
Hz), 7.02–7.33 (6H, m, Ar), 7.62 (2H, d, J = 8.4 Hz, Ar). 13C
NMR (75 MHz, CDCl3): δ = 14.79, 21.46, 25.93, 53.32, 126.40,
126.94, 127.31, 128.46, 129.37, 129.65, 133.05, 137.68, 138.14,
139.94, 142.80, 143.27, 199.65. MS (EI): m/z 91, 155, 222, 223,
224, 225, 296, 297, 298, 334, 344, 346. HRMS (ESI) [M – H]+
calc. for C19H20NO3SCl: requires 378.0925, found: 378.0927.
IR [cm−1]: ν˜ = 3331 (NH), 2954, 1975, 1659, 1598, 1548,
1492, 1415, 1334, 1291, 1162, 1092, 1014, 903, 723, 670.
General procedure (IV) for the reaction of different imines with
MVK (2a) (cf. Table 5)
Methyl vinyl ketone (2a, 1.2 eq.), tosylimine (1b–i, 1.0 eq.) and
4f (5 mol%) as a catalyst were mixed in chloroform. The reaction
was monitored by 1H NMR until the disappearance of the tosyli-
mine was observed. The reaction mixture was directly subjected
to silica gel column chromatography and eluted with ethyl
acetate–isohexane = 1 : 4 to give the corresponding azaMBH
product.
General procedure (V) for the reaction of different imines with
2c (cf. Table 6)
Cyclohexenone (2b, 4.0 eq.), tosylimine (1b–i, 1.0 eq.) and 4f
(25 mol%) as a catalyst were mixed in chloroform. The reaction
was monitored by 1H-NMR until the disappearance of the tosyli-
mine was observed. The reaction mixture was directly subjected
to silica gel column chromatography and eluted with ethyl
acetate–isohexane = 1 : 4 to give the corresponding azaMBH
product.
3aa: 1H NMR (200 MHz, CDCl3): δ = 2.12 (3H, s, Me), 2.40
(3H, s, Me), 5.21 (1H, d, J = 8Hz, NH), 5.72 (1H, d, J = 8.4 Hz,
CH), 6.04 (1H, s), 6.08 (1H, s,), 7.03 (2H, d, J = 8.7Hz, Ar),
7.19 (4H, m, Ar), 7.62 (2H, d, J = 8.0Hz, Ar) (in line with pub-
lished data).7d
3ba: 1H NMR (200 MHz, CDCl3): δ = 2.14 (3H, s, Me), 2.40
(3H, s, Me), 5.26 (1H, d, J = 9.2 Hz), 5.83 (1H, d, J = 8.7Hz),
6.04 (1H, s), 6.10 (1H, s), 7.25 (4H, m, Ar), 7.49 (2H, d, J = 6.7
Hz, Ar), 7.63 (2H, d, J = 7.2 Hz, Ar) (in line with published
data).6b
3ca: 1H NMR (200 MHz, CDCl3): δ = 2.15 (3H, s, Me), 2.42
(3H, s, Me), 5.32 (1H, d, J = 9.4 Hz), 5.91 (1H, d, J = 9.4 Hz),
6.08 (1H, s), 6.13 (1H, s), 7.30 (4H, m, Ar), 7.64 (2H, d, J = 8.3
Hz, Ar), 8.06 (2H, d, J = 8.7 Hz) (in line with published data).26
3ea: 1H NMR (200 MHz, CDCl3): δ = 2.13 (3H, s, Me), 2.41
(3H, s, Me), 5.24 (1H, d, J = 9.1 Hz), 6.00 (1H, s), 6.05 (1H, s),
6.08 (1H, s), 7.21 (2H, d, J = 7.8 Hz), 7.30 (4H, m, Ar), 7.61
(2H, J = 7.8 Hz) (in line with published data).27
3fa: 1H NMR (200 MHz, CDCl3): δ = 2.17 (3H, s, Me), 2.42
(3H, s, Me), 5.29 (1H, d, J = 8.6 Hz), 5.66 (1H, d, J = 8.6 Hz),
6.09 (1H, s), 6.11 (1H, s), 7.11 (2H, m, Ar), 7.21–7.27 (5H, m,
Ar), 7.67 (2H, d, J = 8.1 Hz, Ar) (in line with published data).28
3ga: 1H NMR (200 MHz, CDCl3): δ = 2.15 (3H, s, Me), 2.26
(3H, s, Me), 2.41 (3H, s, Me), 5.26 (1H, d, J = 8.4 Hz), 5.73
(1H, d, J = 8.4 Hz), 6.09 (2H, d, J = 1.0Hz), 6.86–7.03 (4H, m,
Ar), 7.24 (2H, m, Ar), 7.63 (2H, d, J = 8.0 Hz, Ar) (in line with
published data).7d
3ha: 1H NMR (200 MHz, CDCl3): δ = 2.16 (3H, s, Me), 2.42
(3H, s, Me), 3.74 (3H, s, Me), 5.24 (1H, d, J = 8.4 Hz, NH),
5.60 (1H, d, J = 8.4 Hz, CH), 6.09 (2H, m), 6.72 (2H, d, J = 8.2
Hz, Ar), 6.99 (2H, d, J = 8.8 Hz, Ar), 7.25 (2H, d, J = 8.0 Hz,
Ar), 7.65 (2H, d, J = 8.2 Hz, Ar) (in line with published data).7d
3ac: 1H NMR (CDCl3, 200 MHz): δ = 1.62–1.74 (1H, m),
1.77–1.90 (1H, m), 2.03–2.17 (2H, m, CH2), 2.20–2.35 (2H, m,
CH2), 2.40 (3H, s, Me), 5.05 (1H, d, J = 9.4 Hz), 5.96 (1H, d, J
= 9.6 Hz), 6.80 (1H, t, J = 4.4 Hz), 7.09–7.25 (6H, m, Ar), 7.61
(2H, d, J = 7.6 Hz, Ar) (in line with published data).29
3bc: 1H NMR (CDCl3, 300 MHz): δ = 1.64–1.74 (1H, m,
CH2), 1.76–1.79 (1H, m, CH2), 2.05–2.17 (2H, m, CH2),
2.22–2.30 (2H, m, CH2), 2.41 (3H, s, Me), 5.09 (1H, s), 6.02
(1H, s), 6.81 (1H, t, J = 3.0 Hz), 7.25 (2H, d, J = 9.0 Hz, Ar),
7.34 (2H, d, J = 9.0 Hz, Ar), 7.51 (2H, d, J = 6.0 Hz, Ar), 7.63
(2H, d, J = 6.0 Hz, Ar). 13C NMR (CDCl3, 75 MHz): δ = 21.49,
21.87, 25.84, 38.24, 59.50, 111.27, 118.53, 126.98, 127.23,
129.52, 132.14, 136.07, 137.69, 143.52, 144.64, 150.09, 151.07.
MS (EI): m/z 331, 281, 253, 207, 155 (MePhSO2
+), 91 (MePh+).
HRMS (ESI) [M − H]+ calc. for C21H19N2O3S: requires
379.1116, found: 379.1123. IR [cm−1]: 3265 (NH), 3300, 2954,
2924, 2225, 1662 (CvO), 1606, 1598, 1501, 1495, 1423, 1396,
3216 | Org. Biomol. Chem., 2012, 10, 3210–3218 This journal is © The Royal Society of Chemistry 2012
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1330, 1305, 1287, 1248, 1160, 1094, 1079, 1043, 1018, 980,
927, 906, 876, 865, 826, 811, 733, 706.
3cc: 1H NMR (CDCl3, 200 MHz): δ = 1.63–1.70 (1H, m),
1.79–1.87 (1H, m), 2.04–2.13 (2H, m CH2), 2.20–2.36 (2H, m,
CH2), 2.40 (3H, s, Me), 5.14 (1H, d, J = 9.4 Hz), 6.09 (1H, d, J
= 9.4 Hz), 6.83 (1H, t, J = 4.2 Hz), 7.25 (2H, d, J = 6.8 Hz, Ar),
7.39 (2H, d, J = 8.8 Hz, Ar), 7.63 (2H, d, J = 8.4 Hz, Ar), 8.05
(2H, d, J = 7.0 Hz, Ar) (in line with published data).29
3dc: 1H NMR (CDCl3, 300 MHz): δ = 1.75–1.83 (2H, m,
CH2), 2.16–2.30 (4H, m, CH2), 2.36 (1H, s, Me), 5.53 (1H, d, J
= 6.0 Hz), 6.13 (1H, d, J = 6.0 Hz), 7.02–7.33 (6H, m),
7.42–7.44 (1H, m, Ar), 7.62 (2H, d, J = 6.0 Hz, Ar). 13C NMR
(CDCl3, 75 MHz): δ = 21.44, 21.51, 25.83, 38.47, 56.24,
126.44, 126.71, 127.23, 128.52, 129.21, 129.31, 129.48, 129.68,
132.42, 135.77, 136.38, 143.13, 150.14, 199.0. HRMS (ESI)
[M + Na]+ calc. for C20H20ClNNaO3S: requires 412.0750,
found: 412.0743. IR [cm−1]: 3260 (NH), 2953, 2922, 2854,
1675, 1594, 1575, 1494, 1472, 1438, 1379, 1328, 1306, 1286,
1258, 1154, 1136, 1088, 1078, 1037, 980, 952, 913, 854, 815,
756, 744, 715, 705, 699, 608.
3ec: 1H NMR (CDCl3, 300 MHz): δ = 1.61–1.74 (1H, m,
CH2), 1.78–1.88 (1H, m, CH2), 2.07–2.10 (2H, m, CH2),
2.20–2.28 (2H, m, CH2), 2.41 (3H, s, Me), 5.03 (1H, d, J = 6.9
Hz), 5.99 (1H, d, J = 6.9 Hz), 6.80 (1H, t, J = 3.3 Hz), 7.06 (2H,
d, J = 6.3 Hz, Ar), 7.23 (2H, d, J = 6.3 Hz, Ar), 7.33 (2H, d, J =
6.3 Hz, Ar), 7.61 (2H, d, J = 6.3 Hz, Ar). 13C NMR (CDCl3,
75 MHz): δ = 21.48, 21.93, 25.80, 38.33, 59.15, 121.372,
127.26, 128.02,129.44, 131.40, 136.49, 137.72, 138.38, 143.31,
149, 33, 198.87. MS (EI): m/z 334, 281, 207, 183
(MePhSO2NHCH2
+), 171 (MePhSO2NH2
+), 155 (MePhSO2
+),
91 (MePh+). HRMS (ESI) [M]+ calc. for C20H24O3N2BrS:
requires 451.0691, found: 451.0687. IR [cm−1]: 3356
(NH), 3259, 3187, 2925, 2865, 1668 (CvO), 1597, 1527, 1486,
1454, 1423, 1387, 1335, 1303, 1286, 1158, 1092, 1078,
1051, 1007, 980, 957, 933, 917, 905, 814, 797, 736, 708, 688,
660, 633.
3fc: 1H NMR (CDCl3, 200 MHz): δ = 1.61–1.69 (1H, m),
1.77–1.85 (1H, m), 2.02–2.13 (2H, m, CH2), 2.20–2.32 (2H, m,
CH2), 2.39 (3H, s, Me), 5.11 (1H, d, J = 9.2 Hz), 5.98 (1H, d, J
= 9.4 Hz), 6.79 (1H, t, J = 4.2 Hz), 7.15–7.22 (6H, m, Ar), 7.62
(2H, d, J = 8.6 Hz, Ar) (in line with published data).29
3hc: 1H NMR (CDCl3, 600 MHz): δ = 1.62–1.69 (1H, m),
1.78–1.85 (1H, m), 2.03–2.13 (2H, m, CH2), 2.21–2.32 (2H, m,
CH2), 2.40 (3H, s, Me), 3.74 (3H, s, Me), 5.06 (1H, d, J = 9.2
Hz), 5.89 (1H, d, J = 9.4 Hz), 6.72–6.78 (2H, m), 6.82 (1H, s),
7.06 (2H, d, J = 6.8 Hz), 7.22 (2H, d, J = 8.6 Hz, Ar), 7.62 (2H,
d, J = 8.2 Hz, Ar) (in line with published data).29
3ic: 1H NMR (CDCl3, 300 MHz): δ = 1.66–1.78 (1H, m),
1.79–1.93 (1H, m), 2.08–2.22 (2H, m, CH2), 2.23–2.33 (2H, m,
CH2), 2.35 (3H, s, Me), 4.64 (1H, t, J = 6.0 Hz), 5.85 (1H, d, J
= 9.0 Hz), 6.08 (1H, dd, J = 9.0 Hz, J = 6.0 Hz), 6.33 (1H, d, J
= 18 Hz), 6.79 (1H, t, J = 6.0 Hz), 7.19–7.28 (6H, m, Ar), 7.69
(2H, d, J = 9.0 Hz, Ar). 13C NMR (CDCl3, 75 MHz): δ = 21.40,
22.03, 25.77, 38.37, 59.19, 126.45, 126.48, 127.38, 127.80,
128.40, 129.41, 131.53, 136.15, 143.13, 148.53, 199.11. HRMS
(ESI) (M + Na)+ calc. for C22H23NNaO3S: requires 404.1296,
found: 404.1291. IR [cm−1]: 3288 (NH), 3026, 2955, 2924,
2867, 1732, 1660, 1596, 1493, 1447, 1426, 1385, 1326, 1304,
1250, 1213, 1160, 1151, 1090, 1028, 974, 914, 883, 841, 815,
757, 747, 698, 632.
Theoretical procedures
Calculation of reaction free energies ΔG298(CHCl3) for the
addition of catalysts 4k and 5a to Michael acceptors 2a–2c
involve geometry optimization of reactants and products at the
MPW1K/6-31+G(d) level of theory. Thermal corrections to
289.15 K and 1 atm were calculated using the rigid rotor/harmo-
nic oscillator model at the same level of theory. Single point cal-
culations were subsequently performed at MP2(FC)/6-31+G(2d,
p) level of theory and combined with the DFT results to obtain
reaction free energies. Solvation free energies were obtained for
all species through single point calculations with the PCM
model in combination with UAHF radii at the RHF/6-31G(d)
level. Combination of the gas phase free energies with these sol-
vation energies yield, after correcting for the solution standard
state of 1 mol l−1, the free energies in solution at 298.15 K
shown in Fig. 6.17–19 All calculations have been performed using
Gaussian 03, Rev. D.91.15
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Table 6 Results for the azaMBH reaction with cyclohexenone (2c) using 25 mol% catalyst 4f and selected tosylimines as shown in Scheme 8
Entry Ar Tosylimine Time [h] Yieldac [%] Conv.bc [%] Prod.
1 p-NO2-C6H4 1c 24 85 99 3cc
2 p-NC-C6H4 1b 24 88 99 3bc
3 p-Br-C6H4 1e 60 90 99 3ec
4 p-Cl-C6H4 1a 30 98 99 3ac
5 C6H5 1f 60 83 95 3fc
6 p-MeO-C6H4 1h 120 69 90 3hc
7 o-Cl-C6H4 1d 48 84 95 3dc
8 trans-Ph-CHvCH 1i 54 87 96 3ic
a Isolated yield. bDetermined by 1H NMR. c 0.25 M imine, 4.0 eq. ketone 2c.
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